Vasopeptidase Inhibitors [inhibitory vasopeptidas]
- Terms
-
duální inhibitory ACE a NEP
duální inhibitory ACE/NEP
inhibitory vazopeptidáz
inhibitory VEP
NEP/ACE-inhibitory
-
ACE-NEP Inhibitors
NEP-ACE Inhibitors
Vasopeptidase Inhibitor
A class of cardiovascular drugs indicated for hypertension and congestive heart failure that simultaneously inhibit both NEUTRAL ENDOPEPTIDASE and ANGIOTENSIN CONVERTING ENZYME. They increase the availability of NATRIURETIC PEPTIDES and BRADYKININ and inhibit production of ANGIOTENSIN II.
- DUI
- D000075563 MeSH Browser
- CUI
- M000630678
- Previous indexing
- Angiotensin-Converting Enzyme Inhibitors (1999-2017); Neprilysin/antagonists and inhibitors (1999-2017)
- History note
- 2018
- Public note
- 2018
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AA
- analogs & derivatives
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 2
- TO
- toxicity
- UR
- urine